Quantitative Determination of Fluconazole by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry (UPLC-MS/MS) in Human Plasma and its Application to a Pharmacokinetic Study

Abstract

In this study, a simple, rapid and sensitive ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method is described for determination of fluconazole (FLA) in human plasma samples using phenacetin as the internal standard (IS). Sample preparation was accomplished through one-step protein precipitation by methanol, and chromatographic separation was performed on an Acquity BEH C18 column (2.1 mm×50 mm, 1.7 μm) with mobile phase consisted of acetonitrile and water containing 0.1% formic acid (40:60, v/v) at a flow of 0.45 mL/min. Mass spectrometric analysis was performed using a QTrap 5500 mass spectrometer coupled with an electro-spray ionization (ESI) source in the positive ion mode. The MRM transition of m/z 307.2→238.2 was used to quantify for FLA. The linearity of this method was found to be within the concentration range of 10–6 000 ng/mL for FLA in human plasma. Only 1.0 min was needed for an analytical run. The method herein described was superior to previous methods and was successfully applied to the pharmacokinetic study of FLA in healthy Chinese volunteers after oral administration.

Key words

fluconazole - UPLC-MS/MS - plasma - pharmacokinetic study

^* These authors contributed equally to this work.

• References

• 1 Rosa MI, Silva BR, Pires PS et al. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2013; 167: 132-136
• 2 Ethier MC, Science M, Beyene J et al. Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials. Br J Cancer 2012; 106: 1626-1637
• 3 Humphrey MJ, Jevons S, Tarbit MH. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob Agents Chemother 1985; 28: 648-653
• 4 Kim SS, Im HT, Kang IM et al. An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 852: 174-179
• 5 Wattananat T, Akarawut W. Validated HPLC method for the determination of fluconazole in human plasma. Biomed Chromatogr 2006; 20: 1-3
• 6 Belal F, Sharaf El-Din MK, Eid MI et al. Micellar HPLC and Derivative Spectrophotometric Methods for the Simultaneous Determination of Fluconazole and Tinidazole in Pharmaceuticals and Biological Fluids. J Chromatogr Sci 2013;
• 7 Rege AB, Walker-Cador JY, Clark RA et al. Rapid and sensitive assay for fluconazole which uses gas chromatography with electron capture detection. Antimicrob Agents Chemother 1992; 36: 647-650
• 8 Decosterd LA, Rochat B, Pesse B et al. Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin. Antimicrob Agents Chemother 2010; 54: 5303-5315
• 9 Wu D, Wade KC, Paul DJ et al. A rapid and sensitive LC-MS/MS method for determination of fluconazole in human plasma and its application in infants with Candida infections. Ther Drug Monit 2009; 31: 703-709
• 10 Wood PR, Tarbit MH. Gas chromatographic method for the determination of fluconazole, a novel antifungal agent, in human plasma and urine. J Chromatogr 1986; 383: 179-186
• 11 Toyo’oka T. Determination methods for biologically active compounds by ultra-performance liquid chromatography coupled with mass spectrometry: application to the analyses of pharmaceuticals, foods, plants, environments, metabonomics, and metabolomics. J Chromatogr Sci 2008; 46: 233-247